
Medical Editor – Market Access Marketing
Posted 7 hours ago

Posted 7 hours ago
This is a fully remote position, open to applicants in United States.
• Review and refine content for accurate spelling, grammar, and sentence structure.
• Ensure the creative brief is fully met.
• Maintain compliance with AMA and client-specific style guidelines.
• Guarantee appropriate and precise referencing.
• Engage in all phases of content development, from initial outline to printer’s proof.
• Verify facts and collaborate with writers on annotations and references.
• Represent the Editorial team in internal start-up and status meetings.
• Collaborate with the extended team to ensure project completion.
• Confirm that materials align with each client’s MLR submission process.
• Assist with the MLR process.
• Bachelor’s degree in English, Journalism, or a related field.
• Minimum of 3 years of editing experience in the healthcare and/or pharmaceutical industry is required.
• Editorial experience within the pharmaceutical or medical communication sector, or in an advertising agency.
• Comprehensive knowledge of AMA (11th edition) style.
• Proficient in Microsoft Office suite applications.
• Experience with editing in Adobe Acrobat Professional.
• At least 1 year of experience in the advertising and/or pharmaceutical marketing industry is preferred.
• Background in advertising, pharmaceutical marketing, medical communications, and/or medical education is preferred.
• Familiarity with Veeva, Zinc, or MLR reviews and submission systems is preferred.
• Understanding of FDA requirements related to pharmaceutical advertising is preferred.
• Candidates must possess legal authorization to work in the country of employment without employer sponsorship.
• Discretionary annual bonus.
• Health insurance.
• Retirement savings benefits.
• Life insurance.
• Disability benefits.
• Parental leave.
• Paid time off for sick leave and vacation.
Precision Medicine Group
Vericast
Filevine
Gray Media
Get handpicked remote jobs straight to your inbox weekly.